GSK | tickerfilter.com

Fundamental analysis

43%

Profitability 58%

Dept financing 22%

Liquidity 25%

Performance 38%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.48%

1 Month

-0.28%

3 Months

17.50%

6 Months

44.08%

1 Year

48.50%

2 Year

34.47%

Key data

Stock price

$57.07

P/E Ratio

14.50

DAY RANGE

$56.16 - $57.34

EPS

$3.00

52 WEEK RANGE

$32.38 - $61.70

52 WEEK CHANGE

$47.05

MARKET CAP

91.005 B

YIELD

3.44%

SHARES OUTSTANDING

2.073 B

DIVIDEND

$0.4856

EX-DIVIDEND DATE

02-20-2026

NEXT EARNINGS DATE

07-30-2025

BETA

0.37

PUBLIC FLOAT

AVERAGE 10 VOLUME

$5,207,620

AVERAGE 30 VOLUME

$6,626,033

Company detail

CEO: Emma N. Walmsley
Region: US
Website: gsk.com
Employees: 90,100
IPO year: 1986

Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital.

GSK - GSK plc